Gourt > Business > Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer > Research and Development
The phrase research and development (also R and D or R&D) has a special commercial significance apart from its conventional coupling of scientific research and technological development. It is generally added the innovation (R+D+I).
In general, R&D activities are conducted by specialized units or centers belonging to companies, universities and state agencies.
In the context of commerce, "research and development" normally refers to future-oriented, longer-term activities in science or technology, using similar techniques to scientific research without pre-determined outcomes and with broad forecasts of commercial yield.
More on [ Research and development ]
Research and Development :: Pharmaceuticals
@bbb1962 Lol! I see how I got placed in charge of research and development!
ThatGuyBama (Stephen Long) Fri, 06 Nov 2009 05:50:02 -0000
@bbb1962 Lol! I see how I got placed in charge of research and development!
My first company, InterGalactic Research and Development Group, we required each new employee to watch #Buckaroo Banzai on their first day
JohnnyDiggz (Johnny Diggz) Fri, 06 Nov 2009 05:27:13 -0000
My first company, InterGalactic Research and Development Group, we required each new employee to watch #Buckaroo Banzai on their first day
Congress Approves US $50M for Water Power Research and Development ... http://bit.ly/2l8vuK
gasdieselprices (Gas Diesel Prices) Fri, 06 Nov 2009 04:57:55 -0000
Congress Approves US $50M for Water Power Research and Development ... http://bit.ly/2l8vuK
moms and dads of babies and toddlers, latest research in brain development & why the 1st 2 years are so critical.www.inventivemindsgroup.com
babymindexpert (S.H. Jacob Ph. D) Fri, 06 Nov 2009 04:34:18 -0000
moms and dads of babies and toddlers, latest research in brain development & why the 1st 2 years are so critical.www.inventivemindsgroup.com
Research and Markets: Current Development of Leading Chinese IC Design Houses - Chinese IC Design Industry Reached ... http://bit.ly/2CVJfx
techflypaper (Tech Flypaper) Fri, 06 Nov 2009 04:34:10 -0000
Research and Markets: Current Development of Leading Chinese IC Design Houses - Chinese IC Design Industry Reached ... http://bit.ly/2CVJfx
Research and Markets: Current Development of Leading Chinese IC Design Houses ... - Reuters http://bit.ly/22xe6z #china #semicon
ChineseSemicon (China Semicon) Fri, 06 Nov 2009 03:43:04 -0000
Research and Markets: Current Development of Leading Chinese IC Design Houses ... - Reuters http://bit.ly/22xe6z #china #semicon
ARIAD Pharmaceuticals, Inc. - Develops drugs which block intracellular signal transduction pathways for treating solid tumors and hematologic malignancies. Includes kits available, technology overview and investor data from Cambridge, Massachusetts. (Nasdaq: ARIA)
Meta Description: [ ARIAD is developing breakthrough medicines that regulate cell-signaling pathways implicated in cancer. Our pipeline includes a series of small molecule product candidates that provide targeted and highly potent anti-cancer activity to treat solid tumors and hematologic cancers, as well as the spr... ]
Arqule, Inc. - Promotes their activated checkpoint therapy platform. Headquartered in Woburn, Massachusetts. (Nasdaq: ARQL)
Cytogen Corp. - Develops proprietary systems utilizing monoclonal antibodies for the targeted delivery of diagnostic and therapeutic substances in oncology. Includes information for investors, and healthcare professionals in the USA, from Princeton, New Jersey. (Nasdaq: CYTO)
Meta Description: [ Cytogen biopharmaceutical provides Quadramet, a therapeutic agent for the relief of cancer bone pain and Prostascint for detection of prostate cancer. ]
Dendreon Corp. - Discovers and develops immunologically based therapeutic anticancer products. Includes progress of clinical trials, and data for investors from company based in Seattle, Washington. (Nasdaq: DNDN)
Meta Description: [ To target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. ]
Draxis Health Inc. - Produces radiolabeled compounds for diagnostic and therapeutic use in nuclear medicine and oncology. Includes examples that distinguish infection from inflammation, a peptide based on fibrin, and overview of facilities in Kirkland, Québec. [English, French and Spanish]
Exelixis, Inc. - Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and Portland, Oregon. (Nasdaq: EXEL)
Meta Description: [ Exelixis is an integrated drug discovery and development company. Our primary mission is to improve patient care by developing proprietary human therapeutics that target the complex molecular causes of disease. ]
Favrille, Inc. - Biopharmaceutical company focused on the research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system.
Meta Description: [ Favrille ]
Genaera Corp. - Develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. Includes overview of clinical trials, investor information and news from company in Plymouth Meeting, Pennsylvania. (Nasdaq: GENR)
Heal Corporation - Details of projects using resistance related to polyunsaturated fatty acids and catalase in vitro, applied in vivo to trout model. Includes publications, charity status, facilities and contacts in Olympia, Washington.
ImmunoGen, Inc. - Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)
Onyx Pharmaceuticals, Inc. - Discovers and develops small molecule therapeutics based upon the genetics of human disease, with emphasis on cell growth inhibitors. Includes clinical pipeline, technology overview and investor relations at Richmond, California. (Nasdaq: ONXX)
OSI Pharmaceuticals Inc. - Researches and develops diagnostics and anticancer therapy in humans and other diseases associated with control of cell growth. Laboratories in Oxford, Boulder and Farmingdale, headquartered in Melville, New York. (Nasdaq: OSIP)
Panacea Pharmaceuticals, Inc. - Focused on utilizing functional genomics and proteomics to develop therapeutic agents and diagnostic tests for diseases with substantial unmet clinical need.
Meta Description: [ Panacea's is focused on novel proteins and biochemical pathways related to cellular regulation and cell cycle abnormalities in oncology, stroke, Alzheimer's Disease, and Parkinson's Disease. ]
Serenex, Inc. - Drug discovery and development through the commercialization of chemoproteomics, fractionation and mining, purine-binding, mechanism of action determination, and toxicity screening.
Transmolecular, Inc. - Developing treatments in oncology. Includes overview of disease targets, technology, clinical trials, partnering opportunities and contacts for careers in Cambridge, Massachusetts.
Meta Description: [ TransMolecular, Inc. is a biotechnology company committed to discovering, developing, and commercializing novel, targeted therapies for aggressive cancers with limited treatment options. ]
| Roskam & Freshman GOP call for a permanent R&D Tax Credit | |
| Next Video | |
